Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles (Q33642023)

28 July 2017

Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles (English)

1 reference

28 July 2017

0 references

1 reference

Shuyu Xie

1

1 reference

28 July 2017

Baoliang Pan

2

1 reference

28 July 2017

Ming Wang

3

1 reference

28 July 2017

Luyan Zhu

4

1 reference

28 July 2017

Fenghua Wang

5

1 reference

28 July 2017

Zhao Dong

6

1 reference

28 July 2017

Xiaofang Wang

7

1 reference

28 July 2017

WenZhong Zhou

8

1 reference

28 July 2017

1 July 2010

1 reference

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

5

1 reference

28 July 2017

693-701

1 reference

The global status of schistosomiasis and its control

28 July 2017

1 reference

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

21 January 2018

1 reference

Chemotherapy of schistosomiasis: present and future

21 January 2018

1 reference

Investigation of praziquantel metabolism in isolated rat hepatocytes

21 January 2018

1 reference

Chemotherapeutic approaches to schistosomes: current knowledge and outlook

21 January 2018

1 reference

Schistosomiasis control in the 21st century. Proceedings of the International Symposium on Schistosomiasis, Shanghai, July 4-6, 2001.

21 January 2018

1 reference

Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience

21 January 2018

1 reference

Dissolution properties of praziquantel--PVP systems

21 January 2018

1 reference

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

21 January 2018

1 reference

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

21 January 2018

1 reference

Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.

21 January 2018

1 reference

PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution

21 January 2018

1 reference

Interaction between grapefruit juice and praziquantel in humans.

21 January 2018

1 reference

Bioavailability of praziquantel increases with concomitant administration of food

21 January 2018

1 reference

Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins

21 January 2018

1 reference

Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance

21 January 2018

1 reference

Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes

21 January 2018

1 reference

Praziquantel, a new broad-spectrum antischistosomal agent

21 January 2018

1 reference

Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics

21 January 2018

1 reference

Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies

21 January 2018

1 reference

Effects of poly (lactic-co-glycolic acid) as a co-emulsifier on the preparation and hypoglycaemic activity of insulin-loaded solid lipid nanoparticles

21 January 2018

1 reference

Yak interferon-alpha loaded solid lipid nanoparticles for controlled release

21 January 2018

1 reference

Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment

21 January 2018

1 reference

Review of the oral toxicity of polyvinyl alcohol (PVA).

21 January 2018

1 reference

Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake

21 January 2018

1 reference

Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

21 January 2018

1 reference

Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs

21 January 2018

1 reference

Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats

21 January 2018

1 reference

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

21 January 2018

1 reference

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

21 January 2018

1 reference

Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems

21 January 2018

1 reference

Colloidal drug carriers: achievements and perspectives

21 January 2018

1 reference

The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs

21 January 2018

1 reference

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

Solid lipid nanoparticles for parenteral drug delivery.

21 January 2018

1 reference

Subcutaneous drug delivery and the role of the lymphatics

21 January 2018

1 reference

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

21 January 2018

1 reference

Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.10.42

1 reference

28 July 2017

1 reference